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Occasional single-beat regurgitation observed with the new Medtronic
ADVANTAGE bileaflet heart valve
Walter B. Eichinger, MD, PhD,a Ina Wagner, MD,a Sabine Bleiziffer, MD,a Friederike von Canal, MD,b
and Ruediger Lange, MD, PhD,a Munich, Germany
The Medtronic ADVANTAGE prosthesis (Medtronic, Inc, Minneapolis, Minn) is anew bileaflet mechanical heart valve. The multicenter clinical trial to obtainworldwide regulatory approvals for the device began in November 1999. Cur-
rently, the study continues with the follow-up of all enrolled patients until US Food and
Drug Administration approval is granted. In our series containing 61 study patients and
2 patients outside the study with an aortic prosthesis, we echocardiographically observed
an intermittent regurgitation in 7 patients. The intermittent trivial to moderate aortic
regurgitation occurring 1 to 30 times per minute shows higher velocities and a wider
regurgitant jet than the physiologic washing jets in bileaflet valves through the hinge
region.1,2 Neither the frequency nor the degree of regurgitation turned out to be progres-
sive. To further investigate the possible underlying mechanism causing this phenomenon,
we performed fluoroscopy and invasive blood pressure measurement in the ascending
aorta.
Direct visualization of the leaflet motion showed intermittent, asymmetric incomplete
closure of one of the valve leaflets, which could be either one of the 2 leaflets in the same
prosthesis. Each incomplete closure that was visually detected led to a consecutive singular
diastolic pressure decrease in the ascending aorta, reflecting the prosthetic insufficiency.
Simultaneous electrocardiographic recordings proved that this phenomenon was not associ-
ated with arrhythmias (Figure 1).
Thrombotic or other material that might cause a disturbance of leaflet motion could
not be detected. Further investigation is required to determine whether this is an intrinsic
phenomenon of the ADVANTAGE aortic valve. In one of the study centers, an explor-
atory reoperation of an asymptomatic patient showing intermittent regurgitation during
echocardiography was performed under suspicion for valve thrombosis. During the
reoperation, the valve was observed to be normal in appearance and function and was left
in place. In July 2005, Medtronic reported this reoperation as an unanticipated adverse
device effect to the US Food and Drug Administration.
On the basis of our clinical data, we currently do not perform reoperations on these
patients and follow-up these patients closely because they are in good clinical condition
and apparently are not exposed to any risk, except for some intermittent single-beat
regurgitation.
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Complete excision of primary cardiac malignant fibrous histiocytoma
involving the left atrial free wall and mitral annulus by modified
autotransplantation
Chih-Hsien Wang, MD,a Hsi-Yu Yu, MD,a Nai-Shin Chi, MD,a Yih-Sharng Chen, MD,a Kun-Kuang Lee, MD,a
Ya-Jung Cheng, MD,b Lung-Chun Lin, MD,c Wen-Yih Isaac Tseng, MD, PhD,d and Shoei-Shen Wang, MD, PhD,a
Taipei, Taiwan
A44-year-old male patient was referred to our hospitalfor progressive dyspnea on exertion and a cardiactumor disclosed by a computed tomographic imagestudy (Figure 1, A). Operative exploration was per- formed 3 days later, in which a wide-based tumor infiltrating theleft atrial appendage, left atrial anterior free wall, anterior annulusof the mitral valve, and anterior mitral leaflet was found. Tumordebulking and removal of the left atrial appendage were performed
to relieve obstruction by the tumor. Malignant fibrous histiocytoma
was documented by microscopic examination. Follow-up com-
puted tomography performed before his first hospital discharge
revealed residual tumor existing at the anterior atrial wall.
The tumor grew fast, for 30 days, to reach a diameter of 3.6 
3.6 cm2 at his second admission for recurrent dyspneic symptoms.
During the investigation process for possible cardiac allotransplan-
tation, he suddenly experienced shortness of breath and collapsed
in the ward because of nearly total obstruction of the mitral orifice
by the rapid-growing tumor mass. Extracorporeal membrane oxy-
genation (ECMO) was set up on an emergency basis under car-
diopulmonary resuscitation, and he was immediately sent to the
operating room for a radical surgical procedure as his last chance.
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Figure 1. Fluoroscopy of an ADVANTAGE bileaflet valve in the aortic position and
recording of the invasive blood pressure measurement in the ascending aorta with
electrocardiography (ECG). While one leaflet is completely closed, the second leaflet
stays in a slightly open position during the whole diastole (white arrow). The housing and
leaflet edges are radiolucent and cannot be visualized with this technique. Diastolic
blood pressure decrease is associated with each pathologic leaflet motion (black arrow).
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